Home > Signaling Pathways>Neuronal Signaling>5-HT Receptor>Venlafaxine HCl (Wy 45030 HCl)
Venlafaxine HCl (Wy 45030 HCl)

This product is for research use only, not for human use. We do not sell to patients.

Venlafaxine HCl (Wy 45030 HCl)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
5g$745Check With Us
10g$1195Check With Us
20g$1790Check With Us

Cat #: V1024 CAS #: 99300-78-4 Purity ≥ 98%

Description: Venlafaxine (Wy45030; Wy-45030; Effexor, Effexor XR, Lanvexin, Viepax and Trevilor), an approved and arylalkanolamine-based antidepressant, is an serotonin-norepinephrine reuptake inhibitor (SNRI) used to treat various disorders including major depressive disorder (MDD), panic disorder and social phobia, generalised anxiety disorder (GAD).

References: Bymaster FP, et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001 Dec;25(6):871-80.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)313.86
Molecular FormulaC17H27NO2·HCl
CAS No.99300-78-4
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 55 mg/mL (176.8 mM)r
Water: 55 mg/mL (176.8 mM)r
Ethanol: 55 mg/mL (176.8 mM)
SynonymsWy-45030; Trade names: Effexor, Effexor XR, Lanvexin, Viepax and Trevilor. Wy45030; Wy 45030;
ProtocolIn VitroVenlafaxine hydrochloride (Wy 45030 hydrochloride) dose-dependently inhibits binding of the serotonin transporter radioligand [3H]-paroxetine to membranes from cells transfected with the human 5-HT transporter with a Ki of 2.48 μM. Venlafaxine hydrochloride inhibits binding of the NE transporter ligand [3H]-nisoxetine to membranes from cells transfected with the human NE transporter with a Ki of 82 nM
In VivoVenlafaxine hydrochloride (Wy 45030 hydrochloride; 10-100 mg/kg; IP) dose-dependently blocks the depletion of norepinephrine levels in rat hypothalamus induced by 6-OHDA
Animal modelMale Sprague-Dawley rats weighing 180-230 grams
Dosages10, 30, 100 mg/kg
AdministrationIP; one hour prior to p-chloramphetamine hydrochloride (p-CA; 10 mg/kg; i.p.)
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.1861 mL15.9307 mL31.8613 mL63.7227 mL
5mM0.6372 mL3.1861 mL6.3723 mL12.7445 mL
10mM0.3186 mL1.5931 mL3.1861 mL6.3723 mL
20mM0.1593 mL0.7965 mL1.5931 mL3.1861 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.